FIELD: medicine.
SUBSTANCE: group of inventions refers to medicine and may be used in treating infectious diseases. A pharmaceutical composition contains one beta-lactam antibiotic or its pharmaceutically acceptable salt, sulbactam or its pharmaceutically acceptable salt and trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3.2.1]octane-2-carboxamide or its pharmaceutically acceptable salt. The methods according to the invention concern treating a bacterial infection by administering the above composition.
EFFECT: using the inventions enables increasing the clinical effectiveness in bacterial infections.
25 cl, 4 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITIONS, CONTAINING SULBACTAM AND BETA-LACTAMASE INHIBITOR | 2011 |
|
RU2560846C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATING BACTERIAL INFECTIONS CAUSED BY THE MAIN PATHOGENS | 2023 |
|
RU2825961C1 |
| 1,6-DIAZABICYCLO[3,2,1]OCTAN-7-ONE DERIVATIVES AND USING THEM FOR TREATING BACTERIAL INFECTIONS | 2012 |
|
RU2578370C2 |
| 1,6-DIAZABICYCLO[3,2,1]OCTAN-7-ONE DERIVATIVES AND THEIR APPLICATION FOR BACTERIAL INFECTIONS TREATMENT | 2012 |
|
RU2636147C1 |
| 1,6-DIAZABICYCLO[3,2,1]OCTAN-7-ONА DERIVATIVES AND USING THEM IN TREATING BACTERIAL INFECTIONS | 2012 |
|
RU2570423C2 |
| 1,6-DIAZABICYCLO [3,2,1] OCTANE-7-ONA DERIVATIVES AND USE THEREOF FOR TREATING BACTERIAL INFECTIONS | 2013 |
|
RU2614418C2 |
| INTENDED FOR INJECTION COMPOSITIONS FOR OVERCOMING BETA-LACTAMASE-MEDIATED RESISTANCE TO ANTIBIOTICS WITH APPLICATION OF BETA-LACTAMASE INHIBITOR | 2005 |
|
RU2397768C2 |
| NITROGEN-CONTAINING COMPOUNDS AND APPLICATION THEREOF | 2012 |
|
RU2569307C1 |
| ORALLY ADMINISTERED COMBINATIONS OF BETA-LACTAM ANTIBIOTICS AND AVIBACTAM DERIVATIVES FOR TREATING BACTERIAL INFECTIONS | 2020 |
|
RU2825281C1 |
| COMPOSITIONS AND METHODS OF TREATING BACTERIAL INFECTIONS | 2014 |
|
RU2676482C2 |
